Free Trial

NeuroOne Medical Technologies (NMTC) Competitors

NeuroOne Medical Technologies logo
$1.00 +0.06 (+5.99%)
As of 10:33 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NMTC vs. RCEL, NYXH, MBOT, LNSR, LAKE, SPAI, PROF, INO, LUCD, and HYPR

Should you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include Avita Medical (RCEL), Nyxoah (NYXH), Microbot Medical (MBOT), LENSAR (LNSR), Lakeland Industries (LAKE), Safe Pro Group (SPAI), Profound Medical (PROF), Inovio Pharmaceuticals (INO), Lucid Diagnostics (LUCD), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

NeuroOne Medical Technologies vs. Its Competitors

Avita Medical (NASDAQ:RCEL) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

In the previous week, Avita Medical had 5 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 5 mentions for Avita Medical and 0 mentions for NeuroOne Medical Technologies. Avita Medical's average media sentiment score of 0.14 beat NeuroOne Medical Technologies' score of 0.00 indicating that Avita Medical is being referred to more favorably in the media.

Company Overall Sentiment
Avita Medical Neutral
NeuroOne Medical Technologies Neutral

Avita Medical currently has a consensus target price of $11.60, suggesting a potential upside of 111.91%. NeuroOne Medical Technologies has a consensus target price of $2.23, suggesting a potential upside of 122.50%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Avita Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avita Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
NeuroOne Medical Technologies
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

NeuroOne Medical Technologies has a net margin of -55.44% compared to Avita Medical's net margin of -68.87%. NeuroOne Medical Technologies' return on equity of -163.49% beat Avita Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Avita Medical-68.87% -632.62% -71.52%
NeuroOne Medical Technologies -55.44%-163.49%-78.67%

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 2.8% of Avita Medical shares are held by insiders. Comparatively, 8.9% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Avita Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.

NeuroOne Medical Technologies has lower revenue, but higher earnings than Avita Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avita Medical$64.25M2.27-$61.85M-$1.97-2.78
NeuroOne Medical Technologies$3.45M14.49-$12.32M-$0.15-6.67

Summary

Avita Medical and NeuroOne Medical Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get NeuroOne Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NMTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NMTC vs. The Competition

MetricNeuroOne Medical TechnologiesMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$50.05M$7.72B$5.72B$10.39B
Dividend YieldN/A2.76%5.53%4.58%
P/E Ratio-6.6774.1976.1626.62
Price / Sales14.4934.62471.8492.08
Price / CashN/A23.0337.4661.85
Price / Book33.336.8613.336.46
Net Income-$12.32M$245.04M$3.29B$271.49M
7 Day Performance15.61%1.62%2.29%2.97%
1 Month Performance27.45%2.46%4.44%7.56%
1 Year Performance0.57%10.38%75.18%30.09%

NeuroOne Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NMTC
NeuroOne Medical Technologies
2.2322 of 5 stars
$1.00
+6.0%
$2.23
+122.5%
+0.0%$50.05M$3.45M-6.6720Gap Up
RCEL
Avita Medical
2.4223 of 5 stars
$6.25
-7.5%
$11.60
+85.6%
-48.4%$166.37M$74.88M-3.17130High Trading Volume
NYXH
Nyxoah
2.5877 of 5 stars
$4.65
-2.5%
$15.00
+222.6%
-43.1%$158.38M$4.89M-2.02110News Coverage
MBOT
Microbot Medical
2.3228 of 5 stars
$3.34
-2.3%
$12.00
+259.3%
+309.4%$152.14MN/A-5.7620Analyst Downgrade
Gap Up
LNSR
LENSAR
0.9004 of 5 stars
$12.35
+0.1%
$15.00
+21.5%
+184.4%$147.40M$58.36M-2.93110
LAKE
Lakeland Industries
4.8661 of 5 stars
$14.59
+0.7%
$25.00
+71.4%
-26.3%$139.63M$167.21M-5.322,100Analyst Downgrade
SPAI
Safe Pro Group
3.3074 of 5 stars
$7.20
-2.8%
$10.50
+45.8%
+141.0%$135.43M$2.17M-9.0011Positive News
Upcoming Earnings
PROF
Profound Medical
1.726 of 5 stars
$4.04
-1.2%
$11.00
+172.3%
-32.9%$121.69M$11.84M-2.77150News Coverage
INO
Inovio Pharmaceuticals
3.7766 of 5 stars
$2.28
flat
$8.80
+286.0%
-59.0%$121.16M$220K-0.87320
LUCD
Lucid Diagnostics
2.7757 of 5 stars
$1.07
+0.9%
$3.65
+241.1%
+35.3%$116.07M$4.35M-0.9070
HYPR
Hyperfine
1.0859 of 5 stars
$1.41
+1.4%
$1.28
-9.0%
+39.0%$110.80M$12.89M-2.71190

Related Companies and Tools


This page (NASDAQ:NMTC) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners